---
schema_version: "secwatch.filing_event.v1"
accession: "0001125345-26-000040"
form_type: "8-K"
ticker: "MGNX"
cik: "0001125345"
company_name: "MACROGENICS INC"
filed_at: "2026-05-13T20:22:33+00:00"
generated_at: "2026-05-13T21:48:00.408553+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# MacroGenics reports Q1 loss, divests manufacturing, extends cash runway through 2028

## Summary
- Manufacturing operations sold to Bora Pharmaceuticals for $122.5M upfront; expected to close Q3 2026.
- Expanded ZYNYZ royalty monetization with Sagard: $60M received, up to $20M additional milestone.
- Q1 2026 net loss $36.8M ($0.58/share) vs $41.0M loss a year ago; revenue $20.8M (up from $13.2M).
- Cash and securities $154.2M at March 31, 2026; with proceeds, cash runway extended through 2028.
- Pipeline: Initial MGC026 ADC data expected mid-2026; MGC028 data H2 2026; MGC030 IND planned Q3 2026.

## SEC filing metadata
- accession: 0001125345-26-000040
- form_type: 8-K
- ticker: MGNX
- cik: 0001125345
- company_name: MACROGENICS INC
- filed_at: 2026-05-13T20:22:33+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000040/0001125345-26-000040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000040/mgnx-20260513.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001125345-26-000040
- JSON: https://secwatch.observer/filing/0001125345-26-000040.json
- Plain text: https://secwatch.observer/filing/0001125345-26-000040.txt

## Key facts
- Earnings Releases
  MACROGENICS INC reported financial results for the quarter ended March 31, 2026.
  - Period: the quarter ended March 31, 2026
  - Result: reported results
  source text: On May 13, 2026, MacroGenics, Inc. (the "Company") announced financial and operating results as of and for the quarter ended March 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1125345/000112534526000040/0001125345-26-000040-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.